ARTICLE | Company News
Debiopharm, Medical Futures Inc. sales and marketing update
February 25, 2008 8:00 AM UTC
Debiopharm granted Medical Futures an exclusive license to market Sanvar vapreotide acetate to treat acute esophageal variceal bleeding (EVB) in Canada, where the somatostatin analog is under review....